Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness
When we released “Weed” in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.It’s not just public perception. The science over the last six years has grown by leaps and bounds, as well. Epidiolex, a pharmaceutical-grade CBD oil, went through clinical trials and is being prescribed for thousands of patients with seizures. The founder of GW Pharmaceuticals, the maker of Epidiolex, told me they are now developing cannabis medications for everything from autism to anxiety.
Stories you may be interested in
Medical Marijuana a Hit With Seniors
In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers. Nine out of 10 liked it so much they said they’d recommend medical pot to others. “I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you,” said one senior. Another patient put…
Read More 
Substance in cannabis ‘could boost pancreatic cancer treatments’
A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More 
Unstructured EHR data more useful for predictive analytics, study shows
A new report in the Journal of the American Medical Informatics Association has shown that real-world data contained in unstructured narratives has big predictive value when it comes to clinical research. WHY IT MATTERSWhile structured clinical notes in the electronic health record have obvious value, the research in JAMIA suggests that real-world data captured in unstructured notes…
Read More 
Norfolk research company plans clinical trials using medical marijuana
Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More 
World Cancer Day – Shine a Light on the World
In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More 
New Feature: Calendar Integration
At Arfinn Med, we’re excited to announce the third feature update to join automated text messaging and note templating: calendar integration. With this addition, physicians can now integrate their Google Calendar or Calendy account. The implementation of calendar integration rounds out the Arfinn Med portal, making it a physician’s one-stop-shop EMR tool. How It Works…
Read More